This study will identify important barriers to and facilitators of translating an efficacious diabetes prevention intervention (Group Lifestyle Balance, GLB) into routine clinical practice, outside of a research context.
Aims include: (1) Evaluate the clinical effectiveness of GLB, (2) Evaluate the impact of GLB on healthcare utilization, costs, and cost-effectiveness, and (3) Evaluate GLB implementation within and across Sutter Health regions and clinics.
National Institute of Diabetes and Digestive and Kidney Diseases
April 01, 2017
March 31, 2022
Accelerating Adoption of Comparative Effectiveness Research Results with Patient Decision Support Interventions
Investigator(s): Robert Romanelli, Ph.D., MPH
Investigator(s): Kristen M.J. Azar, R.N., BSN, MSN/MPH